Wednesday, March 05, 2025 | 01:37 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

AstraZeneca resumes US Covid-19 vaccine trial, optimism seen for J&J

AstraZeneca's US trial was paused on September 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial

Covid-19 coronavirus
Premium

AstraZeneca's vaccine is being developed along with researchers at Oxford University

Reuters
AstraZeneca Plc has resumed the US trial of its experimental Covid-19 vaccine after approval by US regulators, the company said on Friday.

AstraZeneca's US trial was paused on September 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial.

US Health and Human Services Deputy Chief of Staff Paul Mango also told reporters he was optimistic a US trial by Johnson & Johnson would resume.

J&J paused its large, late-stage trial last week after a study participant became ill and the company said an independent safety panel was investigating.

AstraZeneca trials in

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in